In this issue:
Hepcidin-guided interventions for children with iron-deficiency anaemia
Eprenetapopt + azacitidine after allogeneic SCT for TP53-mutant AML/MDS
RT vs. autologous SCT for primary CNS lymphoma
Mutations that impact outcomes of lower-risk MDS
PROs with second-line axi-cel in large B-cell lymphoma
Bosutinib for newly diagnosed chronic-phase CML
Consolidation obinutuzumab after chemoimmunotherapy in CLL
Jaktinib for myelofibrosis
Bispecific LV20.19 CAR T-cells for relapsed/refractory B-cell malignancies
Salvage haploidentical or cord-blood allogeneic SCT for haematological malignancies
Please login below to download this issue (PDF)